← The Ultimate Human with Gary Brecka
Loading summary
Transcript1 lines
- [00:00]
A
You've heard of Ozempic, you've probably heard of Manjaro. Maybe you've even heard people call these medications game changers. And they are. People were losing 10, 12, 15% of their body weight in a clinical trial that was unprecedented for a medication. These are the most powerful weight loss medications ever developed. And that power comes with a responsibility that most people are not being told about at the prescriber's office. Today, we're talking about GLP1 medications, specifically, how we got here, why the newest generation is unlike anything we've ever seen. And the two things every single person on these drugs needs to be doing that most prescribers are not even mentioning. In some studies, reductions in lean Mass accounted for 40 to 60% of the total weight lost. That is not a weight loss win. That is a metabolic loss that will affect your resting energy expenditure, your strength, your functional health, and your ability to keep the weight off long term. If you're on a GLP1 medication right now and you're not lifting and you're not prioritizing protein, you are losing lean muscle and you will spend years trying to rebuild it back. This is a complete non negotiable part. If you are on GLP1s, You've heard of Ozempic, you've probably heard of Manjaro. Maybe you've even heard people call these medications game changers. And they are. But. But the conversation almost always stops at one number. How much weight did you lose? And almost nobody is asking the more important question, what kind of weight? Because here's the truth. Losing weight and losing fat are not the same thing. And if you're on one of those medications without doing two specific things, you might be trading muscle for a number on the scale. And that trade will cost you for years. I'm biohacker and human biologist Gary Breca, and you're listening to the ultimate human podcast where we dig into the real science behind longevity and disease prevention. Today, we're talking about GLP1 medications, specifically how we got here, why the newest generation is unlike anything we've ever seen. And the two things every single person on these drugs needs to be doing that most prescribers are not even mentioning. Let's start with the history, because it matters. GLP1 stands for glucagon. Like peptide 1, a hormone your gut actually releases after you eat, that signals your brain to reduce appetite, slows digestion, and helps regulate blood sugar. About two decades ago, researchers figured out how to mimic that signal pharmacologically. The first generation of these drugs, Semaglutide, sold as Ozempic and wegovy, targeted the GLP1 receptor alone. A single agonist 1 signal. And the results were significant. People were losing 10, 12, 15% of their body weight in a clinical trial that was unprecedented for a medication. Then came tirzepatide, Manjaro, Zepp bound. This was a dual agonist. It targeted GLP1 and a second receptor called GIP, glucose dependent insulinotropic polypeptide. Two signals instead of one. The metabolic effect was stronger. Weight loss numbers climbed. And then came retatrutide, which is a triple agonist. GLP1, GIP, and now a third, the glucagon receptor. A 2024 review published in Endocrinology and Metabolism traced this full arc and reported that the phase 2 clinical TR for retatrutide at 12 milligrams produced 24.2% mean body weight loss at 48 weeks. That is the highest number ever published for a pharmacological obesity treatment ever. And it's not even fully approved yet. It's still in phase three trials. So this is where the science really gets going. Each generation added a receptor. Each time, the results got stronger. That's not coincidence. That's biology responding to a more complete signal. But here's where I need you to pay attention very, very closely. The more powerful the weight loss signal, the more critical it becomes to protect what you're losing. Because these medications suppress your appetite very aggressively. They slow your stomach, they quiet hunger in a way that feels like a solution. And it is for fat loss. But that same appetite suppression applies to protein, the building blocks your body desperately needs to maintain lean muscle mass. A 2024 review published in Diabetes, Obesity and Metabolism examined lean body mass changes across GLP clinical trials and found that in some studies, reductions in lean Mass accounted for 40 to 60% of the total weight lost. Let me say that again. 60% of the weight loss was from muscle dense tissue. That is not a weight loss win. That is a metabolic loss that will affect your resting energy expenditure, your strength, your functional health and your ability to keep the weight off long term. So, yes, these are the most powerful weight loss medications ever developed. And that power comes with a responsibility that most people are not being told about at the prescriber's office. The fix is not complicated, but it's non negotiable. The same review from Mount Sinai and Harvard was direct. All patients on these medications should be in comprehensive programs that emphasize two things. Adequate, high quality protein Intake and resistance training. Not cardio, not general activity, resistance training specifically because it sends the signal your body needs to hold on to that valuable muscle while it's shedding fat. So for protein, Your goal is 0.7 to 1 gram per pound of body weight daily. Even when you're not hungry. Especially when you're not hungry. GLP1s will suppress your appetite across the entire spectrum. So you have to be intentional about hitting your protein targets. Prioritize leucine rich sources, meat, eggs, even dairy. My preference is raw dairy. They are the most direct drivers of muscle protein synthesis. Resistance training at least three sessions per week, incorporating compound movements, squats, deadlifts, rows, presses. This is a complete non negotiable part. If you are on GLP1s, you are sending a biological signal to your body that this muscle is being used and it needs to be retained. If you're interested in Learning more about GLP1s and metabolic health, watch this episode we filmed with Dr. Tina Moore. She's an expert in metabolic health with years and years of experience. She covers everything related to GLP1s, including insulin resistance and metabolic syndrome. It's a great episode and I highly recommend you check it out as we close up here today. Remember, weight loss medications do not know the difference between fat and muscle. Your training and your protein intake are what tell it to keep the muscle. These drugs are tools. In fact, the most powerful tools we've ever had for fat loss. But a tool without a protocol is just potential. If you're on a GLP1 medication right now and you're not lifting and you're not prioritizing protein, you are losing lean muscle and you will spend years trying to rebuild it back. Use the medication, do the work. That's the complete protocol and that's just science.